| Cause of death |  | Fisher's | ||||
---|---|---|---|---|---|---|---|
 | Alive (%) | Cardio-respiratory failure (%) | Pneumonia (%) | Regional met (%) | Distant met (%) | Total |  |
Differentiation | Â | Â | Â | Â | Â | Â | Â |
Well | 24 (28.9) | 3 (60.0) | 3 (50.0) | 1 (10.0) | 1 (9.1) | 32 | Â |
Moderate | 47 (56.6) | 2 (40.0) | 3 (50.0) | 2 (20.0) | 6 (54.5) | 60 | Â |
Moderate-poorly | 8 (9.6) | 0 (0.0) | 0 (0.0) | 2 (20.0) | 1 (9.1) | 11 | Â |
Poorly | 4 (4.8) | 0 (0.0) | 0 (0.0) | 5 (50.0) | 3 (27.3) | 12 | 0.001 |
pTNM | Â | Â | Â | Â | Â | Â | Â |
T1N0M0 | 53 (63.9) | 2 (40.0) | 2 (33.3) | 0 (0.0) | 1 (9.1) | 58 | Â |
T2N0M0 | 20 (24.1) | 1 (20.0) | 2 (33.3) | 0 (0.0) | 0 (0.0) | 23 | Â |
T1N1M0 | 4 (4.8) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 1 (9.1) | 6 | Â |
T2N1M0 | 2 (2.4) | 1 (20.0) | 1 (16.7) | 2 (20.0) | 0 (0.0) | 6 | Â |
T1N2aM0 | 1 (1.2) | 0 (0.0) | 0 (0.0) | 3 (30.0) | 2 (18.2) | 6 | Â |
T2N2aM0 | 0 (0.0) | 1 (20.0) | 1 (16.7) | 2 (20.0) | 5 (45.5) | 9 | Â |
T1N2bM0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 0 (0.0) | 1 | Â |
T2N2bM0 | 1 (1.2) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 1 (9.1) | 3 | Â |
T1N2cM0 | 1 (1.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (9.1) | 2 | Â |
T2N2cM0 | 1 (1.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 | <0.001 |
IF, cohesive | 64 (78.0) | 5 (6.1) | 5 (6.1) | 5 (6.1) | 3 (3.7) | 82 | Â |
IF, non-cohesive | 19 (57.6) | 0 (0.0) | 1 (3.0) | 5 (15.2) | 8 (24.2) | 33 | 0.002 |
Dys. At Margin | 33 (62.3) | 1 (1.9) | 2 (3.8) | 8 (15.1) | 9 (17.0) | 53 | 0.005 |
Lymphvascular Invasion | 13 (46.4) | 1 (3.6) | 2 (7.1) | 6 (21.4) | 6 (21.4) | 28 | 0.002 |
Nerve Invasion | 5 (41.7) | 0 (0.0) | 0 (0.0) | 3 (25.0) | 4 (33.3) | 12 | 0.011 |
B/C Invasion | 2 (40.0) | 0 (0.0) | 0 (0.0) | 1 (20.0) | 2 (40.0) | 5 | 0.131 |
SD present | 49 (68.1) | 3 (4.2) | 3 (4.2) | 7 (9.7) | 10 (13.9) | 72 | 0.271 |
Tumour clearance | 82 (76.6) | 5 (4.7) | 5 (4.7) | 6 (5.6) | 9 (8.4) | 107 | <0.001 |
Recurrence | 19 (44.2) | 2 (4.7) | 1 (2.3) | 10 (23.3) | 11 (25.6) | 43 | <0.001 |
Total | 83 | 5 | 6 | 10 | 11 | Â | Â |